World Wires · Story 120439 · official · 1 Quelle(n)

SCHEDULE 13D/A: Redmile Group, LLC discloses a stake in Fate Therapeutics Inc

Filed: 2026-11-09 AccNo: 0000905148-26-004718 Size: 31 KB

Im Desk öffnen

Berichterstattung

• SCHEDULE 13D/A: Redmile Group, LLC discloses a stake in Fate Therapeutics Inc SEC EDGAR: Schedule 13D stakes · Stufe A · Clear Net · 2026-11-10 00:08 UTC

Was diese Seite indexiert